1198171-18-4

Basic information

• Product Name: 1-Bromo-2-(difluoromethyl)-4-fluorobenzene
• Synonyms: 1-Bromo-2-(difluoromethyl)-4-fluorobenzene
• CAS NO: 1198171-18-4
• Molecular Formula: C₇H₄BrF₃
• Molecular Weight: 225.0058696
• Mol File: 1198171-18-4.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Bromo-2-(difluoromethyl)-4-fluorobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-2-(difluoromethyl)-4-fluorobenzene(1198171-18-4)
• EPA Substance Registry System: 1-Bromo-2-(difluoromethyl)-4-fluorobenzene(1198171-18-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1198171-18-4(Hazardous Substances Data)

Usage

General Description

1-Bromo-2-(difluoromethyl)-4-fluorobenzene is a chemical compound with the molecular formula C7H4BrF3. It is a colorless liquid that is commonly used as an intermediate in the production of pharmaceuticals, agrochemicals, and other organic compounds. This chemical is an important building block in the synthesis of various fluorinated organic molecules and is also used in the creation of specialty materials and fine chemicals. It is important to handle 1-Bromo-2-(difluoromethyl)-4-fluorobenzene with care, as it is a hazardous substance that can cause irritation to the skin, eyes, and respiratory system if not properly handled.

Upstream product

• 94569-84-3 2-bromo-5-fluorobenzaldehyde 

Downstream Products

• 1198171-20-8 2-(difluoromethyl)-4-fluorobenzaldehyde 
• 1614246-61-5 (4-bromo-3-(difluoromethyl)phenyl)(ethyl)sulfane 
• 1614246-62-6 1-bromo-2-(difluoromethyl)-4-(ethylsulfonyl)benzene 
• 1214326-61-0 2-(difluoromethyl)-4-fluorophenol 

Relevant articles and documents

PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS

The present invention provides a compound of Formula (I): (I) or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).

PYRIDAZINONES AND METHODS OF USE THEREOF

Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I).

Chemical Compounds

The present invention relates to imidazopyridazine derivatives. More particularly, it relates to 4-(biphenyl-3-yl)-7H-imidazo[4,5-c]pyridazine derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are as defined in the description. The imidazopyridazine derivatives of the present invention modulate the activity of the GABAA receptor. They are useful in the treatment of a number of conditions, including pain.